Vein Therapy News Vein Therapy News
  • Home
  • Physicians
  • Digital Issue
    • Latest Issue
    • Back Issues
  • Events
  • Industry News
  • Advertise
  • Subscribe
  • Advisory Board
  • Contact
  • Home
  • Physicians
  • Digital Issue
    • Latest Issue
    • Back Issues
  • Events
  • Industry News
  • Advertise
  • Subscribe
  • Advisory Board
  • Contact
  • 12 Dec 2022 Cook Medical Appoints John A. Kaufman as Chief Medical Officer
  • 12 Dec 2022 Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage
  • 12 Dec 2022 Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study
  • 11 Aug 2022 Starting a vein practice? Start here!
  • 15 Jul 2022 FDA Breakthrough Device designation
  • 15 Jul 2022 Alucent’s natural vascular scaffolding to be evaluated in ACTIVATE II FIH trial
  • 15 Jul 2022 Koya Medical’s Dayspring compression system launched for lower extremity treatment of lymphedema and venous disorders
  • 15 Jul 2022 AngioDynamics Auryon system to be studied in BTK arteries

Post Box with 3-Cols Boxed Grid Layout

Dr. John A. Kaufman

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

December 12, 2022
0
Embocubes

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

December 12, 2022
0
Vesalio device

Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

December 12, 2022
0

Post Box with Ajax Pagination

Dr. John A. Kaufman

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

December 12, 2022
0
Embocubes

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

December 12, 2022
0
Vesalio device

Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

December 12, 2022
0
Page :
1 2 3 4 … 99

Post Box with 3-Cols Block Grid Layout

Dr. John A. Kaufman
12 Dec 2022

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon

Vein Therapy News 0
Embocubes
12 Dec 2022

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is

Vein Therapy News 0
Vesalio device
12 Dec 2022

Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a

Vein Therapy News 0

Post Box with 2-Cols Boxed Grid Layout and Sidebar

Dr. John A. Kaufman
12 Dec 2022

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon

Vein Therapy News 0
Embocubes
12 Dec 2022

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is

Vein Therapy News 0

Post Box with 3-Cols Masonry Layout

Dr. John A. Kaufman
12 Dec 2022

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon

Vein Therapy News 0
Embocubes
12 Dec 2022

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is

Vein Therapy News 0
Vesalio device
12 Dec 2022

Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a

Vein Therapy News 0
ScleroTech Vein Therapy Solutions
11 Aug 2022

Starting a vein practice? Start here!

Quality Training All Treatment Modalities You, your staff, your patients in the comfort of your own office. Real hands on training! Our on-site consultant Joyce Vining RVT, LPN 25 years experience treating vein disease. Venous Ultrasound | Endovenous Ablation | Phlebectomy | Sclerotherapy Need Office Forms, Photos, and Patient Education?

Vein Therapy News 0
15 Jul 2022

FDA Breakthrough Device designation

Cook Medical announced that its Thoraco+ endovascular system has received Breakthrough Device designation from the FDA. The company describes Thoraco+ as a next- generation, off-the-shelf device in the Zenith platform, indicated for patients with thoracoabdominal aortic aneurysms (Crawford classification I-IV). It has four side branches for the celiac, superior mesenteric,

Vein Therapy News 0
15 Jul 2022

Alucent’s natural vascular scaffolding to be evaluated in ACTIVATE II FIH trial

Alucent Biomedical Inc. announced that it has enrolled the first patient in ACTIVATE II, an Australia-based first-in-human clinical trial to evaluate the safety and efficacy of AlucentNVS, the company’s natural vascular scaffolding device. According to the company, the ACTIVATE II trial will enroll up to 50 patients at up to

Vein Therapy News 0
  • Dr. John A. Kaufman
    News

    Cook Medical Appoints John A. Kaufman as Chief Medical Officer

    Vein Therapy News — December 12, 2022
  • Embocubes
    News

    Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

    Vein Therapy News — December 12, 2022
  • Vesalio device
    News

    Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

    Vein Therapy News — December 12, 2022

Post Carousel

  • Dr. John A. Kaufman
    News

    Cook Medical Appoints John A. Kaufman as Chief Medical Officer

  • Embocubes
    News

    Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

  • Vesalio device
    News

    Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

  • ScleroTech Vein Therapy Solutions
    The Practice

    Starting a vein practice? Start here!

  • News

    FDA Breakthrough Device designation

Post Box with Classic Layout and Sidebar

Dr. John A. Kaufman
12 Dec 2022

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon

Vein Therapy News 0 Read More
Embocubes
12 Dec 2022

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is

Vein Therapy News 0 Read More
Vesalio device
12 Dec 2022

Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a

Vein Therapy News 0 Read More

Latest Posts

Dr. John A. Kaufman
News

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Embocubes
News

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

Vesalio device
News

Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study

Recent Posts

  • Cook Medical Appoints John A. Kaufman as Chief Medical Officer
  • Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage
  • Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study
  • Starting a vein practice? Start here!
  • FDA Breakthrough Device designation

Categories

  • Business News
  • Case Studies
  • Education
  • Events
  • Government
  • LYMPHEDEMA
  • News
  • Payers
  • Physicians
  • Product News
  • Researchers
  • SecondLook
  • Subscription
  • The Practice
  • VTN Advisory Board

Custom Content Section

You can place any content here, including Advertising. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque scelerisque lectus nec est feugiat, at eleifend sapien suscipit. Cras in neque ac nulla blandit auctor sed ut purus. Curabitur metus elit, tristique id auctor a, fermentum imperdiet felis. Maecenas imperdiet facilisis nibh at viverra. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Cras euismod rhoncus nibh, et vestibulum justo bibendum et. Quisque sed vehicula erat. Nulla cursus a nisi a tincidunt. Curabitur pulvinar, urna quis volutpat dignissim, libero est fermentum mauris, ut rutrum metus lacus at ipsum. Donec rhoncus leo eget dolor gravida ullamcorper. Suspendisse tempus, velit condimentum hendrerit ultrices, tellus libero auctor leo, non feugiat libero dui a tellus.

  • Home
  • Physicians
  • Events
  • Latest Issue
  • Industry News
  • Subscribe
  • Advisory Board
  • Advertise
  • Contact
  • Privacy Policy
  • PHYSICIAN-COMPOUNDED FOAM
Copyright ©, 2020 Vein Therapy News. Publications & Communications, LP. All Rights Reserved. Designated trademarks and brands are the property of their respective owners.


SHARE

Page Composer – All Blocks